Table: Chugai Pharm -6-MTH group results (IFRS)

Chugai Pharmaceutical

25/07/2019 08:00

Jul 25 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2019        Jun 30, 2018     Dec 31, 2019 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              320.29              285.12                     
                   (+12.3 pct)         (+12.8 pct)                  
  Operating           95.05               66.57                     
                   (+42.8 pct)         (+41.3 pct)                  
  Pretax
  Net                 69.25               48.67                     
                   (+42.3 pct)         (+34.8 pct)                  
  EPS Basic        126.54 yen           89.00 yen                   
  EPS Diluted      126.35 yen           88.85 yen                   
  Ann Div                               86.00 yen        96.00 yen  
  -Q2 Div           48.00 yen           31.00 yen                   
  -Q4 Div                               55.00 yen        48.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T